General Information of the Compound
Compound ID |
CP0015520
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
4-[3-(pyridin-2-yl)-1H-pyrazol-4-yl]quinoline
Show/Hide
|
||||||||||||||||||
Synonyms |
396129-53-6
4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)quinoline
4-(3-PYRIDIN-2-YL-1H-PYRAZOL-4-YL)QUINOLINE
4-(3-Pyridin-2-YL-1H-pyrazol-4-YL)quinoline
4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline
4-(3-pyridin-2-yl)(1h)-pyrazol-4-yl quinoline
4-[3-(2-Pyridinyl)-1H-pyrazol-4-yl]quinoline
4-[3-(pyridin-2-yl)-1H-pyrazol-4-yl]quinoline
ALK5 Inhibitor I
CHEMBL261454
HTS-466284
LY 364947
LY-364947
LY364947
TGF-beta RI Kinase Inhibitor
TbetaR-I Inhibitor
Transforming Growth Factor-beta Type I Receptor Kinase Inhibitor
[3-(Pyridin-2-yl)-4-(4-quinonyl)]-1H-pyrazole
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C17H12N4
|
||||||||||||||||||
Molecular Weight |
272.311
|
||||||||||||||||||
Canonical SMILES |
c1[nH]nc(c1-c1ccnc2ccccc12)-c1ccccn1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C17H12N4/c1-2-6-15-13(5-1)12(8-10-19-15)14-11-20-21-17(14)16-7-3-4-9-18-16/h1-11H,(H,20,21)
Show/Hide
|
||||||||||||||||||
InChIKey |
IBCXZJCWDGCXQT-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01221, TGF-beta receptor type-1
Protein ID: PT01867, TGF-beta receptor type-2
Clinical Information about the Compound
Drug 1 ( HTS-466284 )
Drug Name | HTS-466284 | ||
---|---|---|---|
Target(s) |
TGF-beta receptor type I (TGFBR1)
Inhibitor
|